PharmChem Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
1998
1999
2000
2001
2002
Sales/Revenue
43,172.00
44,487.00
46,832.00
43,977.00
30,085.00
Cost of Goods Sold (COGS) incl. D&A
31,838.00
31,559.00
33,100.00
32,623.00
23,013.00
Gross Income
11,334.00
12,928.00
13,732.00
11,354.00
7,072.00
SG&A Expense
10,125.00
10,174.00
11,341.00
12,016.00
7,855.00
Unusual Expense
-
-
-
6,896.00
-
Non Operating Income/Expense
2.00
15.00
12.00
18.00
66.00
Interest Expense
293.00
284.00
281.00
431.00
651.00
Pretax Income
921.00
2,506.00
2,133.00
8,005.00
1,363.00
Income Tax
286.00
294.00
772.00
471.00
69.00
Consolidated Net Income
635.00
2,800.00
1,361.00
8,476.00
1,294.00
Net Income
635.00
2,800.00
1,361.00
8,476.00
1,294.00
Net Income After Extraordinaries
635.00
2,800.00
1,361.00
8,476.00
5,930.00
Net Income Available to Common
635.00
2,800.00
1,361.00
8,476.00
1,294.00
EPS (Basic)
0.10
0.47
0.22
1.45
0.57
Basic Shares Outstanding
5,764.00
5,786.00
5,822.00
5,851.00
5,853.00
EPS (Diluted)
0.10
0.47
0.22
1.45
0.57
Diluted Shares Outstanding
6,238.00
5,954.00
6,069.00
5,851.00
5,853.00
EBITDA
3,208.00
4,811.00
4,643.00
1,635.00
1,468.00
Non-Operating Interest Income
3.00
21.00
11.00
2.00
137.00
About PharmChem
View Profile
